October 17, 2025 · Form 4 insider transaction
Bitterman Kevin sold 1,125 shares of Disc Medicine, Inc. at $84.89 per share, a transaction worth $95.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
These shares are held by Atlas Venture Opportunity Fund I, LP ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, LP ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.